Today's health news spans major policy failures in pandemic PPE spending, breakthrough menopause treatment approval, advances in Alzheimer's diagnosis through blood tests, and emerging concerns about cancer risks and cardiovascular health screening.

Baroness Hallett's fifth COVID inquiry report reveals that two-thirds of the UK's £10 billion PPE spending was wasted, with significant sums directed through a 'VIP lane' favoring politically connected suppliers, raising serious accountability questions.

Scotland's Medicines Consortium has approved fezolinetant, the first non-hormonal menopause drug, for restricted NHS use in women unable to tolerate hormone replacement therapy, offering a new treatment option for vasomotor symptoms.

A new blood test enables primary care physicians to diagnose Alzheimer's disease with near-specialist accuracy, influencing referral patterns and treatment decisions while potentially improving early detection in community settings.

Many medical schools fall short of nationally recommended paid parental leave standards for faculty members, highlighting workplace equity gaps within academic medicine institutions.

The rapid aging of Baby Boomers is driving increased demand for minimally invasive cardiac procedures and AI-powered tools to address the complex healthcare needs of older patients.

Patients with acromegaly face significantly elevated risks for colorectal and thyroid cancers, though overall long-term cancer mortality remains comparable to the general population, suggesting targeted screening may be warranted.

Carotid artery wall thickness can serve as an early marker of cardiovascular changes, potentially identifying at-risk individuals before they develop symptoms of heart disease.

Active surveillance of cervical intraepithelial neoplasia grade 2 carries similar risks for adverse pregnancy outcomes as immediate excision of the transformation zone, offering women more conservative management options.